Table 1 Characteristics of the study populations
Groups (number; male/female) | Age (years) | Duration of disease (years) | TSH (μU/ml) | fT3 (pmol/l) | fT4 (pmol/l) | TPOAb/TRAb/TgAb positive (number) | CMV IgG positive/negative (number) |
|---|---|---|---|---|---|---|---|
HC (70; 27/43) | 13.7 ± 4.0 (14.6; 5.0 – 28.5) | n. a. | 0.9 ± 0.3 (0.8; 0.7 – 1.2) | 5.4 ± 1.0 (4.9; 4.7 – 6.6) | 14.6 ± 1.9 (15.5; 12.3 – 15.9) | 0/0/1 | 21/49 |
HT (18; 4/14) | 14.1 ± 5.8 (13.6; 4.2 – 34.3) | 3.1 ± 2.5 (3.3; 0.3-7.3) | 6.9 ± 12.2 (2.1; 0.2 – 50.4) * | 5.9 ± 1.2 (5.9; 4.1 – 8.8) | 14.34 ± 3.1 (15.0; 8.4 – 19.1) | 18/17/18 | 5/13 |